Teleflex (NYSE:TFX - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Teleflex to post earnings of $3.86 per share and revenue of $813.24 million for the quarter. Individual interested in listening to the company's earnings conference call can do so using this link.
Teleflex Trading Up 0.2 %
Teleflex stock traded up $0.30 during mid-day trading on Friday, hitting $175.43. 397,701 shares of the company's stock were exchanged, compared to its average volume of 491,425. The company's 50 day simple moving average is $177.07 and its 200-day simple moving average is $207.80. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $8.15 billion, a P/E ratio of 34.88, a PEG ratio of 1.73 and a beta of 1.16. Teleflex has a fifty-two week low of $165.62 and a fifty-two week high of $249.90.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Truist Financial cut their price target on shares of Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research note on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Monday, December 16th. Finally, Mizuho reduced their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $252.50.
Check Out Our Latest Stock Analysis on TFX
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
